The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Research Report 2025
Synopsis
The global Continuous Glucose Monitoring (CGM) Systems for Diabetics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM) Systems for Diabetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM) Systems for Diabetics.
Report Scope
The Continuous Glucose Monitoring (CGM) Systems for Diabetics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Glucose Monitoring (CGM) Systems for Diabetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring (CGM) Systems for Diabetics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diabetes Care Inc.
Dexcom
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Segment by Type
Wearable
Implantable
Segment by Application
Hospitals & Clinics
Homecare Settings
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) Systems for Diabetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Glucose Monitoring (CGM) Systems for Diabetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Continuous Glucose Monitoring (CGM) Systems for Diabetics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring (CGM) Systems for Diabetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring (CGM) Systems for Diabetics.
Report Scope
The Continuous Glucose Monitoring (CGM) Systems for Diabetics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuous Glucose Monitoring (CGM) Systems for Diabetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuous Glucose Monitoring (CGM) Systems for Diabetics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Diabetes Care Inc.
Dexcom
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Segment by Type
Wearable
Implantable
Segment by Application
Hospitals & Clinics
Homecare Settings
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuous Glucose Monitoring (CGM) Systems for Diabetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuous Glucose Monitoring (CGM) Systems for Diabetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Overview
1.1 Product Overview and Scope of Continuous Glucose Monitoring (CGM) Systems for Diabetics
1.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Segment by Type
1.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Value Comparison by Type (2024-2030)
1.2.2 Wearable
1.2.3 Implantable
1.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Segment by Application
1.3.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Value by Application: (2024-2030)
1.3.2 Hospitals & Clinics
1.3.3 Homecare Settings
1.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size Estimates and Forecasts
1.4.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue 2019-2030
1.4.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales 2019-2030
1.4.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Competition by Manufacturers
2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price by Manufacturers (2019-2024)
2.4 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Continuous Glucose Monitoring (CGM) Systems for Diabetics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuous Glucose Monitoring (CGM) Systems for Diabetics, Product Type & Application
2.7 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Competitive Situation and Trends
2.7.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Continuous Glucose Monitoring (CGM) Systems for Diabetics Players Market Share by Revenue
2.7.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Retrospective Market Scenario by Region
3.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region: 2019-2030
3.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region: 2019-2024
3.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region: 2025-2030
3.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region: 2019-2030
3.3.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region: 2019-2024
3.3.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region: 2025-2030
3.4 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
3.4.1 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2030)
3.4.3 North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
3.5.1 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2030)
3.5.3 Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
3.6.1 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2030)
3.6.3 Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
3.7.1 Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2030)
3.7.3 Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Type (2019-2030)
4.1.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Type (2019-2024)
4.1.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Type (2025-2030)
4.1.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Type (2019-2030)
4.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Type (2019-2030)
4.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Type (2019-2024)
4.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Type (2025-2030)
4.2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Type (2019-2030)
4.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Application (2019-2030)
5.1.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Application (2019-2024)
5.1.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Application (2025-2030)
5.1.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Application (2019-2030)
5.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Application (2019-2030)
5.2.1 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Application (2019-2024)
5.2.2 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Application (2025-2030)
5.2.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Application (2019-2030)
5.3 Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Diabetes Care Inc.
6.1.1 Abbott Diabetes Care Inc. Corporation Information
6.1.2 Abbott Diabetes Care Inc. Description and Business Overview
6.1.3 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
6.1.5 Abbott Diabetes Care Inc. Recent Developments/Updates
6.2 Dexcom
6.2.1 Dexcom Corporation Information
6.2.2 Dexcom Description and Business Overview
6.2.3 Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
6.2.5 Dexcom Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Senseonics Holdings
6.4.1 Senseonics Holdings Corporation Information
6.4.2 Senseonics Holdings Description and Business Overview
6.4.3 Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
6.4.5 Senseonics Holdings Recent Developments/Updates
6.5 GlySens Incorporated
6.5.1 GlySens Incorporated Corporation Information
6.5.2 GlySens Incorporated Description and Business Overview
6.5.3 GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
6.5.5 GlySens Incorporated Recent Developments/Updates
6.6 Meiqi Medical Equipment
6.6.1 Meiqi Medical Equipment Corporation Information
6.6.2 Meiqi Medical Equipment Description and Business Overview
6.6.3 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
6.6.5 Meiqi Medical Equipment Recent Developments/Updates
6.7 San Meditech
6.6.1 San Meditech Corporation Information
6.6.2 San Meditech Description and Business Overview
6.6.3 San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Product Portfolio
6.7.5 San Meditech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Industry Chain Analysis
7.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Production Mode & Process
7.4 Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales and Marketing
7.4.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Channels
7.4.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Distributors
7.5 Continuous Glucose Monitoring (CGM) Systems for Diabetics Customers
8 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Dynamics
8.1 Continuous Glucose Monitoring (CGM) Systems for Diabetics Industry Trends
8.2 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Drivers
8.3 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Challenges
8.4 Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Competitive Situation by Manufacturers in 2023
Table 4. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Continuous Glucose Monitoring (CGM) Systems for Diabetics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Continuous Glucose Monitoring (CGM) Systems for Diabetics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Continuous Glucose Monitoring (CGM) Systems for Diabetics, Product Type & Application
Table 12. Global Key Manufacturers of Continuous Glucose Monitoring (CGM) Systems for Diabetics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring (CGM) Systems for Diabetics as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region (2019-2024) & (K Units)
Table 18. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Region (2019-2024)
Table 19. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region (2025-2030) & (K Units)
Table 20. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Region (2025-2030)
Table 21. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Region (2019-2024)
Table 23. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Region (2025-2030)
Table 25. North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2024) & (K Units)
Table 27. North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2025-2030) & (K Units)
Table 28. North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2024) & (K Units)
Table 32. Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2025-2030) & (K Units)
Table 33. Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units) by Type (2019-2024)
Table 51. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units) by Type (2025-2030)
Table 52. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Type (2019-2024)
Table 53. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Type (2025-2030)
Table 54. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Type (2019-2024)
Table 57. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Type (2025-2030)
Table 58. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price (US$/Unit) by Type (2019-2024)
Table 59. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price (US$/Unit) by Type (2025-2030)
Table 60. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units) by Application (2019-2024)
Table 61. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units) by Application (2025-2030)
Table 62. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Application (2019-2024)
Table 63. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Application (2025-2030)
Table 64. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Application (2019-2024)
Table 67. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Application (2025-2030)
Table 68. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price (US$/Unit) by Application (2019-2024)
Table 69. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price (US$/Unit) by Application (2025-2030)
Table 70. Abbott Diabetes Care Inc. Corporation Information
Table 71. Abbott Diabetes Care Inc. Description and Business Overview
Table 72. Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abbott Diabetes Care Inc. Continuous Glucose Monitoring (CGM) Systems for Diabetics Product
Table 74. Abbott Diabetes Care Inc. Recent Developments/Updates
Table 75. Dexcom Corporation Information
Table 76. Dexcom Description and Business Overview
Table 77. Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Dexcom Continuous Glucose Monitoring (CGM) Systems for Diabetics Product
Table 79. Dexcom Recent Developments/Updates
Table 80. Medtronic Corporation Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Medtronic Continuous Glucose Monitoring (CGM) Systems for Diabetics Product
Table 84. Medtronic Recent Developments/Updates
Table 85. Senseonics Holdings Corporation Information
Table 86. Senseonics Holdings Description and Business Overview
Table 87. Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Senseonics Holdings Continuous Glucose Monitoring (CGM) Systems for Diabetics Product
Table 89. Senseonics Holdings Recent Developments/Updates
Table 90. GlySens Incorporated Corporation Information
Table 91. GlySens Incorporated Description and Business Overview
Table 92. GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. GlySens Incorporated Continuous Glucose Monitoring (CGM) Systems for Diabetics Product
Table 94. GlySens Incorporated Recent Developments/Updates
Table 95. Meiqi Medical Equipment Corporation Information
Table 96. Meiqi Medical Equipment Description and Business Overview
Table 97. Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Meiqi Medical Equipment Continuous Glucose Monitoring (CGM) Systems for Diabetics Product
Table 99. Meiqi Medical Equipment Recent Developments/Updates
Table 100. San Meditech Corporation Information
Table 101. San Meditech Description and Business Overview
Table 102. San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. San Meditech Continuous Glucose Monitoring (CGM) Systems for Diabetics Product
Table 104. San Meditech Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Continuous Glucose Monitoring (CGM) Systems for Diabetics Distributors List
Table 108. Continuous Glucose Monitoring (CGM) Systems for Diabetics Customers List
Table 109. Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Trends
Table 110. Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Drivers
Table 111. Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Challenges
Table 112. Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Continuous Glucose Monitoring (CGM) Systems for Diabetics
Figure 2. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Share by Type in 2023 & 2030
Figure 4. Wearable Product Picture
Figure 5. Implantable Product Picture
Figure 6. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Share by Application in 2023 & 2030
Figure 8. Hospitals & Clinics
Figure 9. Homecare Settings
Figure 10. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size (2019-2030) & (US$ Million)
Figure 12. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales (2019-2030) & (K Units)
Figure 13. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Average Price (US$/Unit) & (2019-2030)
Figure 14. Continuous Glucose Monitoring (CGM) Systems for Diabetics Report Years Considered
Figure 15. Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Share by Manufacturers in 2023
Figure 16. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Continuous Glucose Monitoring (CGM) Systems for Diabetics Players: Market Share by Revenue in 2023
Figure 18. Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Country (2019-2030)
Figure 21. North America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Country (2019-2030)
Figure 22. United States Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Country (2019-2030)
Figure 25. Europe Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Country (2019-2030)
Figure 26. Germany Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Region (2019-2030)
Figure 33. China Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Country (2019-2030)
Figure 43. Latin America Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Continuous Glucose Monitoring (CGM) Systems for Diabetics Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Type (2019-2030)
Figure 53. Global Revenue Market Share of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Type (2019-2030)
Figure 54. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Application (2019-2030)
Figure 56. Global Revenue Market Share of Continuous Glucose Monitoring (CGM) Systems for Diabetics by Application (2019-2030)
Figure 57. Global Continuous Glucose Monitoring (CGM) Systems for Diabetics Price (US$/Unit) by Application (2019-2030)
Figure 58. Continuous Glucose Monitoring (CGM) Systems for Diabetics Value Chain
Figure 59. Continuous Glucose Monitoring (CGM) Systems for Diabetics Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
